These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 33525562)

  • 1. Lithium and Therapeutic Targeting of GSK-3.
    Snitow ME; Bhansali RS; Klein PS
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating GSK3 as an in vivo target of lithium action.
    O'Brien WT; Klein PS
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1133-8. PubMed ID: 19754466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium and synaptic plasticity.
    Salinas PC; Hall AC
    Bipolar Disord; 1999 Dec; 1(2):87-90. PubMed ID: 11252664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium.
    Marmol F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1761-71. PubMed ID: 18789369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The history of lithium therapy.
    Shorter E
    Bipolar Disord; 2009 Jun; 11 Suppl 2(Suppl 2):4-9. PubMed ID: 19538681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder.
    Munkholm K; Miskowiak KW; Jacoby AS; Vinberg M; Leme Talib L; Gattaz WF; Kessing LV
    Eur Neuropsychopharmacol; 2018 Mar; 28(3):361-368. PubMed ID: 29433844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium pharmacodynamics and pharmacogenetics: focus on inositol mono phosphatase (IMPase), inositol poliphosphatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta).
    Serretti A; Drago A; De Ronchi D
    Curr Med Chem; 2009; 16(15):1917-48. PubMed ID: 19442155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte phosphoglucomutase activity of bipolar I patients currently using lithium or carbamazepine.
    Montero-Lomelí M; Galvão D; Morais BB; Nardi AE
    Braz J Med Biol Res; 2007 Jan; 40(1):19-25. PubMed ID: 17224992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular effects of lithium.
    Quiroz JA; Gould TD; Manji HK
    Mol Interv; 2004 Oct; 4(5):259-72. PubMed ID: 15471909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
    Malhi GS; Outhred T
    CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium and valproic acid: parallels and contrasts in diverse signaling contexts.
    Gurvich N; Klein PS
    Pharmacol Ther; 2002 Oct; 96(1):45-66. PubMed ID: 12441177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wnt signaling pathway in bipolar disorder.
    Gould TD; Manji HK
    Neuroscientist; 2002 Oct; 8(5):497-511. PubMed ID: 12374432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium response viewed as a biomarker to predict developmental psychopathology in offspring with bipolar disorder: a commentary.
    Pavuluri MN; Lee MS; Pandey G
    Bipolar Disord; 2015 Mar; 17(2):224-32. PubMed ID: 25523965
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lithium: 55 years of history in the therapy of bipolar affective disorder].
    Mármol F
    Med Clin (Barc); 2006 Jul; 127(5):189-95. PubMed ID: 16834956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview.
    Bortolozzi A; Fico G; Berk M; Solmi M; Fornaro M; Quevedo J; Zarate CA; Kessing LV; Vieta E; Carvalho AF
    Pharmacol Rev; 2024 May; 76(3):323-357. PubMed ID: 38697859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. John Cade and lithium.
    Walter G
    Psychiatr Serv; 1999 Jul; 50(7):969. PubMed ID: 10402625
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte Phospho-Ser-9-GSK-3β/Total GSK-3β Protein Levels Ratio Is Not Affected by Chronic Lithium or Valproate Treatment in Euthymic Patients With Bipolar Disorder.
    Azab AN; Vainer E; Agam G; Bersudsky Y
    J Clin Psychopharmacol; 2017 Apr; 37(2):226-230. PubMed ID: 28106616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is phosphoadenosine phosphate phosphatase a target of lithium's therapeutic effect?
    Shaltiel G; Deutsch J; Rapoport SI; Basselin M; Belmaker RH; Agam G
    J Neural Transm (Vienna); 2009 Nov; 116(11):1543-9. PubMed ID: 19756369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.
    Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P
    J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.